IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 417.24 USD -0.31% Market Closed
Market Cap: 34.2B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

IDEXX Laboratories Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEXX Laboratories Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
IDEXX Laboratories Inc
NASDAQ:IDXX
Revenue
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%
No Stocks Found

IDEXX Laboratories Inc
Revenue Breakdown

Breakdown by Geography
IDEXX Laboratories Inc

Total Revenue: 3.7B USD
100%
Americas: 2.6B USD
71.7%
Europe, The Middle East And Africa: 716.2m USD
19.6%
Asia Pacific Region: 319.3m USD
8.7%
Canada: 150.1m USD
4.1%
Switzerland: 34.8m USD
1%
Show More
Show Less

Breakdown by Segments
IDEXX Laboratories Inc

Total Revenue: 3.7B USD
100%
Cag Segment Revenue: 3.4B USD
91.6%
Cag Diagnostics Recurring Revenue:: 2.9B USD
80.2%
Product Revenue: 2.1B USD
57.1%
Service Revenue: 1.6B USD
42.9%
Reference Laboratory Diagnostic And Consultin...: 1.3B USD
34.9%
Rapid Assay Products: 344.5m USD
9.4%
Veterinary Software, Services And Diagnostic ...: 279.3m USD
7.6%
Water Segment Revenue: 168.1m USD
4.6%
Cag Diagnostics Capital - Instruments: 137.6m USD
3.8%
Lpd Segment Revenue: 121.7m USD
3.3%
Other Segment Revenue: 18.8m USD
0.5%
Show More
Show Less

IDEXX Laboratories Inc
Glance View

Market Cap
34.3B USD
Industry
Health Care

IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster their presence in both developed and emerging markets. For investors, IDEXX represents a compelling opportunity within a steadily growing sector. The company's recurring revenue model, driven by its suite of diagnostic tests and subscriptions to software solutions, ensures stable cash flow and predictability in earnings. IDEXX has also demonstrated impressive financial performance, characterized by strong revenue growth, high profit margins, and a commitment to shareholder returns. By harnessing trends in pet ownership and increasing expenditures on pet healthcare, IDEXX positions itself as a reliable player in the marketplace. With its dedication to innovation, customer service, and global expansion, IDEXX Laboratories Inc. stands poised for sustained growth, making it an attractive consideration for long-term investors.

IDXX Intrinsic Value
253.04 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is IDEXX Laboratories Inc's Revenue?
Revenue
3.8B USD

Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Revenue amounts to 3.8B USD.

What is IDEXX Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for IDEXX Laboratories Inc have been 7% over the past three years , 10% over the past five years , and 10% over the past ten years .

Back to Top